EyeCheckup - early diagnosis logo — EyeCheckup is an early diagnosis system for preventing visio...

EyeCheckup - early diagnosis

EyeCheckup is an early diagnosis system for preventing vision loss using artificial intelligence.

Founded 2020 United Kingdom London, United Kingdom 4 employees Seed Total: $5.87M AI, Health Care

General Information

Company Name EyeCheckup - early diagnosis
Founded Year 2020
Location United Kingdom London, United Kingdom
Employees 4
Industries AI, Health Care
Funding Stage Seed
Business Model B2B, SaaS
Revenue Model Subscription, Usage Based, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with EyeCheckup - early diagnosis. To contact EyeCheckup - early diagnosis, visit eye-checkup.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does EyeCheckup - early diagnosis compare?

A PDF of EyeCheckup - early diagnosis and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting EyeCheckup - early diagnosis soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About EyeCheckup - early diagnosis

EyeCheckup is a promising startup revolutionizing the healthcare industry with its cutting-edge Artificial Intelligence technology aimed at preventing vision loss. Founded in 2020, this United Kingdom-based company leverages AI to provide an early diagnosis of major retinal diseases such as Diabetic Retinopathy, Glaucoma, and Age-related Macula Degeneration via retinal fundus imaging.

The company has positioned itself within the intersection of the AI and Health Care industries, offering innovative solutions that promise to alleviate the global burden of vision impairment. As of 08 December 2023, EyeCheckup received a $650.00K Seed Round investment, led by Arz Portfolio. This funding marks a significant milestone, underscoring strong investor confidence in their technology-driven approach to vision diagnosis. Investors seeking AI-driven healthcare innovations will find EyeCheckup a company worth watching.

Business keywords: Healthcare Diagnostics, Retinal Diseases, Vision Loss Prevention, Diabetic Retinopathy, Glaucoma, Age-related Macular Degeneration, Retinal Fundus Imaging, Early Diagnosis System, AI-based Diagnosis, Primary Care Access, Health Insurance Coverage, Blindness Prevention, Eye Health Technology, Ophthalmology Software

Services & Products

AI-based diagnostics for eye diseases
Diagnosis of chronic diseases (CKD, CVD) using AI
Anomaly detection in retinal images
Automated grading and labeling of eye disease pathologies

Target Customers

Hospitals and medical institutions Ophthalmologists General healthcare providers Patients with eye diseases

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $650.00K 1
Arz Portfolio
08 Dec 2023
Seed Round $5.00M 1
Techmine Venture Capital Investment Trust
29 Dec 2021
Non Equity Assistance Undisclosed 1
Hackquarters
21 Apr 2021
Pre Seed Round $150.00K 3
TÜBİTAK, Kosgeb +1
01 Jan 2021
Seed Round $70.00K 1
Dale Brodsky
03 Dec 2020

EyeCheckup - early diagnosis Alternatives & Competitors

View All Alternatives
EyeCheckup - early diagnosis vs
Spect
Spect United States

Our mission is to prevent blindness

Seed
19 employees
AI, Health Care
EyeCheckup - early diagnosis vs
Eyenuk, Inc.
Eyenuk, Inc. United States

Global artificial intelligence (AI) medical technology and services company

24 employees
AI, Health Care
EyeCheckup - early diagnosis vs
eye2you
eye2you Germany

Eye care everywhere

Pre-Seed
2 employees
AI, Digital Health

FAQ About EyeCheckup - early diagnosis

EyeCheckup is an early diagnosis system for preventing vision loss using artificial intelligence.
EyeCheckup - early diagnosis was founded in 2020.
EyeCheckup - early diagnosis is headquartered in London, United Kingdom.
EyeCheckup - early diagnosis operates in AI and Health Care. Its work centres on Healthcare Diagnostics, Retinal Diseases, Vision Loss Prevention and Diabetic Retinopathy. Its customers include Hospitals and medical institutions, Ophthalmologists and General healthcare providers.
EyeCheckup - early diagnosis has a B2B and SaaS business model. Its revenue comes from Subscription, Usage Based and Service Fee.
EyeCheckup - early diagnosis has approximately 4 employees.
EyeCheckup - early diagnosis has completed 5 funding rounds, raising a total of $5.87M. The latest funding stage is Seed.
EyeCheckup - early diagnosis offers: AI-based diagnostics for eye diseases, Diagnosis of chronic diseases (CKD, CVD) using AI, Anomaly detection in retinal images, Automated grading and labeling of eye disease pathologies.
Top alternatives and competitors to EyeCheckup - early diagnosis include Spect, Eyenuk, Inc., eye2you, RetinAI, Oivi. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
EyeCheckup - early diagnosis and Spect are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for EyeCheckup - early diagnosis, https://bouncewatch.com/company/eyecheckup, updated 22 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes